Delivery Order SPE2DB20D1100-SPE2DB24FA0J9
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, a firm fixed price delivery order, is for the supply of Mycophenolate 500 mg tablets. The contract has a ceiling value of $2,073.55 and a period of performance through April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mycophenolate 500 mg tablets. The firm-fixed-price delivery order has a ceiling value of $2,991.75 and a period of performance through April 16, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award, valued at $2,216.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4557731908 - Mycophenolic Acid DR 360 mg TB 120s, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 8, 2022. There is no set-aside designation mentioned for this award....
- This federal contract award, valued at $1,612.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,923,836 units of Mycophenolic Acid DR 360 mg Tablets, and has a period of performance through April 16, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...
- This federal contract award is for $1,950.54 and was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $3,066.66 by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of MYCOPHENOLATE 500 MG TABLET 500S, a pharmaceutical product, with a completion date of January 26, 2024. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through...
- This federal contract award, valued at $114,021.60, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a firm fixed price delivery order. The award is for the provision of pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities. This delivery order falls under a larger indefinite delivery contract (IDC) valued up to...
- This federal contract award, valued at $2,353.70, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the provision of pharmaceutical products and medical supplies to support military treatment programs and facilities. Amerisourcebergen Drug Corp serves as the prime contractor on this...
- This federal contract award is a delivery order valued at $1,908.12 issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of pharmaceutical products and medical supplies to support military treatment programs and facilities. Amerisourcebergen Drug Corp serves as the prime contractor and there is no set-aside designation for...
- This federal contract award, valued at $2,405.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary mechanism for Amerisourcebergen to deliver a...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA0J9Delivery Order
This federal contract award, valued at $2,281.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the supply of Mycophenolate 200 mg/ml suspension, a specialty pharmaceutical product, with a completion date of February 5, 2024. Amerisourcebergen Drug Corp is the prime contractor, and this award is part of the company's broader contract vehicles with DLA, including an indefinite delivery contract valued at up to $999,999,999.00 that serves as the primary means for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this particular award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 2/2/24 |